By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merck KGaA 

Frankfurter Street 250

Darmstadt    D-64293  Germany
Phone: 49-6151-720 Fax: 49-6151-722000




SmithKline Beecham 

ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in diabetes and obesity.

GlaxoSmithKline (North Carolina) 

TargeGen, Inc.  Licensing Agreement - Vascular Biology Portfolio.

Company News
Threshold Pharma (THLD) And Merck KGaA (MKGAF.PK), Darmstadt, Germany Agree To Key Terms For The Licensing Back Of All Rights To Evofosfamide To Threshold 1/12/2016 12:32:33 PM
Merck KGaA (MKGAF.PK), Darmstadt, Germany, Pfizer (PFE) And Syndax Announce Collaboration To Evaluate Combination Of Avelumab And Entinostat In Ovarian Cancer 1/4/2016 7:46:12 AM
Merck KGaA (MKGAF.PK), Pfizer (PFE) Accelerate Immuno-Oncology Drug Avelumab into Phase III Ovarian and Bladder Cancer Trials 12/22/2015 6:39:29 AM
Struggling Ariad (ARIA) Nets Former Merck KGaA (MKGAF.PK) Exec as New CEO 12/18/2015 6:17:45 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) Initiate Two Phase III Studies Of Investigational Immunotherapy Avelumab In Advanced Gastric And Gastro-Esophageal Junction Cancers 12/9/2015 10:45:54 AM
Threshold Pharma (THLD) Crumbles as Merck KGaA (MKGAF.PK) Abandons Cancer Drug After Trial Failures 12/7/2015 6:00:29 AM
Threshold Pharma (THLD) Enters Into Definitive Co-Promotion Agreement For Evofosfamide With Merck KGaA (MKGAF.PK), Darmstadt, Germany 11/19/2015 12:35:08 PM
Merck KGaA (MKGAF.PK), Darmstadt, Germany, Completes Sigma-Aldrich (SIAL) Acquisition 11/18/2015 10:26:44 AM
FDA Calls Merck KGaA (MKGAF.PK), Pfizer (PFE)'s Skin Cancer Drug Avelumab a Breakthrough 11/18/2015 6:30:37 AM
Threshold Pharma (THLD) Extends $550 Million Deal with Merck KGaA (MKGAF.PK) for 50% of Cancer Drug’s U.S. Sales 11/18/2015 5:42:55 AM